Spectrumedics joins J&J MedTech’s Shockwave and Elixir Medical as the only other companies with EU-approved IVL systems.

Ad feature presented by Shockwave Medical. The treatment giving people the potential to live an ordinary life after heart ...

Shockwave Medical, Inc. SWAV, along with Genesis MedTech Group, received approval from China’s National Medical Products Administration for Intravascular Lithotripsy (“IVL”). The clearance paves the ...

Johnson & Johnson (J&J) MedTech’s Shockwave Medical has launched the E⁸ peripheral intravascular (IVL) catheter in the US for patients living with certain types of peripheral artery disease (PAD).

SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...

A detailed agenda for all Shockwave Medical symposia and featured presentations can be found here. While under clinical investigation in the COSIRA-II trial (U.S. and Canada), the Reducer is CE-marked ...